Safety and Effectiveness of Onon Drysyrup (Pranlukast hydrate) in Children Aged Less Than 1 year with Bronchial Asthma

DOI 2 Citations 4 References

Bibliographic Information

Other Title
  • １歳未満の気管支喘息に対するオノンドライシロップ１０％（プランルカスト水和物）製造販売後調査結果（第２報）―長期投与症例の追跡調査―
  • ―長期投与症例の追跡調査―

Search this article

Description

A post-marketing surveillance study was carried out to investigate the safety and efficacy of long-term administration of Onon Dry Syrup 10% (Pranlukast hydrate) in actual clinical settings in patients who were traceable among those eligible for the former prospective survey. A total of 55 cases were collected from 33 medical institutions all over Japan. Thirty four patients were under the medication for more than 1 year.<BR>Among 55 patients included in the safety analysis population, an adverse drug reaction occurred in 1 case (incidence of 1.82%), which was a non-serious case of liver function disorder.<BR>Among 50 patients included in the efficacy analysis population, 46 showed improvement (improvement rate of 92.0%). The result of the analysis by patient background factors showed no special concern with the effectiveness of the drug.<BR>In conclusion, it was confirmed that Onon Dry Syrup is a highly safe and effective medication for bronchial asthma when administered in infants aged less than 1 year for a long-time of period.

Journal

Citations (2)*help

See more

References(4)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top